BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, June 7, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 5, 2013
View Archived Issues
Development of a potassium channel activator for the treatment of migraine
Read More
Novel phosphate adsorbers for the treatment of patients with renal failure
Read More
miRNA improves survival in a murine model of ALS
Read More
Development of two novel murine models of filarial pathology
Read More
Biotest and EpiVax to develop non-immunogenic treatment for hemophilia A
Read More
Stallergenes and ActoGeniX to develop treatments for allergic diseases
Read More
OncoMed and Celgene sign agreement for anti-cancer stem cell product candidates
Read More
Anti-infective startup company Auspherix launched
Read More
RXi Pharmaceuticals reports additional data from phase I RXI-109 trial
Read More
Genentech begins phase II trial of DNIB-0600A
Read More
Novel Nampt inhibitors presented by AbbVie
Read More
Novel muscarinic M4 positive allosteric modulator for the treatment of Huntington's disease
Read More
Incyte Corp. presents new JAK1 inhibitors
Read More
Researchers at Actelion Pharmaceuticals synthesize novel LXA4 receptor agonists
Read More
Idera Pharmaceuticals opens enrollment in phase I/II trial of IMO-8400
Read More
Glenmark Pharmaceuticals discloses novel ROR-gamma modulators
Read More
GlaxoSmithKline patents new EZH2 inhibitors for cancer
Read More
Bristol-Myers Squibb synthesizes new GPR119 receptor agonists
Read More
3-V Biosciences begins phase I TVB-2640 trial
Read More
Galapagos reports phase I findings on GLPG-1205
Read More
Sanofi launches ComPlavin combination tablets in Japan
Read More
Topline data reported from phase II study of ChemoCentryx's CCX-168
Read More
FDA grants orphan drug designation to Immunomedics' IMMU-132 for SCLC
Read More
The Medicines Company gains anti-infective assets through Rempex acquisition
Read More
Puma Biotechnology reports data from I-SPY 2 trial of neratinib
Read More
OncoMed studies vantictumab combination therapy for pancreatic cancer
Read More
